Preferred β-lactone synthesis can explain high rate of false-negative results in the detection of OXA-48-like carbapenemases.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
23 12 2022
Historique:
received: 21 04 2022
accepted: 19 12 2022
entrez: 23 12 2022
pubmed: 24 12 2022
medline: 28 12 2022
Statut: epublish

Résumé

The resistance to carbapenems is usually mediated by enzymes hydrolyzing β-lactam ring. Recently, an alternative way of the modification of the antibiotic, a β-lactone formation by OXA-48-like enzymes, in some carbapenems was identified. We focused our study on a deep analysis of OXA-48-like-producing Enterobacterales, especially strains showing poor hydrolytic activity. In this study, well characterized 74 isolates of Enterobacterales resistant to carbapenems were used. Carbapenemase activity was determined by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS), liquid chromatography/mass spectrometry (LC-MS), Carba-NP test and modified Carbapenem Inactivation Method (mCIM). As meropenem-derived β-lactone possesses the same molecular weight as native meropenem (MW 383.46 g/mol), β-lactonization cannot be directly detected by MALDI-TOF MS. In the spectra, however, the peaks of m/z = 340.5 and 362.5 representing decarboxylated β-lactone and its sodium adduct were detected in 25 out of 35 OXA-48-like producers. In the rest 10 isolates, decarboxylated hydrolytic product (m/z = 358.5) and its sodium adduct (m/z = 380.5) have been detected. The peak of m/z = 362.5 was detected in 3 strains co-producing OXA-48-like and NDM-1 carbapenemases. The respective signal was identified in no strain producing class A or class B carbapenemase alone showing its specificity for OXA-48-like carbapenemases. Using LC-MS, we were able to identify meropenem-derived β-lactone directly according to the different retention time. All strains with a predominant β-lactone production showed negative results of Carba NP test. In this study, we have demonstrated that the strains producing OXA-48-like carbapenemases showing false-negative results using Carba NP test and MALDI-TOF MS preferentially produced meropenem-derived β-lactone. We also identified β-lactone-specific peak in MALDI-TOF MS spectra and demonstrated the ability of LC-MS to detect meropenem-derived β-lactone.

Identifiants

pubmed: 36564543
doi: 10.1038/s41598-022-26735-5
pii: 10.1038/s41598-022-26735-5
pmc: PMC9789108
doi:

Substances chimiques

carbapenemase EC 3.5.2.6
Meropenem FV9J3JU8B1
Bacterial Proteins 0
beta-Lactamases EC 3.5.2.6
Anti-Bacterial Agents 0
Carbapenems 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

22235

Informations de copyright

© 2022. The Author(s).

Références

J Glob Antimicrob Resist. 2017 Dec;11:98-99
pubmed: 29030313
Clin Microbiol Rev. 2013 Jan;26(1):103-14
pubmed: 23297261
Angew Chem Int Ed Engl. 2018 Jan 26;57(5):1282-1285
pubmed: 29236332
Proc Natl Acad Sci U S A. 2001 Dec 4;98(25):14280-5
pubmed: 11724923
Folia Microbiol (Praha). 2011 Jul;56(4):361-5
pubmed: 21818609
Front Microbiol. 2020 Jan 21;10:3095
pubmed: 32038543
Diagn Microbiol Infect Dis. 2017 Mar;87(3):295-297
pubmed: 27993422
J Clin Microbiol. 2017 Aug;55(8):2321-2333
pubmed: 28381609
Chem Biol. 2009 May 29;16(5):540-7
pubmed: 19477418
Infect Dis Clin North Am. 1997 Dec;11(4):875-87
pubmed: 9421705
Antimicrob Agents Chemother. 2018 Oct 24;62(11):
pubmed: 30104282
J Antimicrob Chemother. 2015 Apr;70(4):1059-63
pubmed: 25583748
Antimicrob Agents Chemother. 2018 Aug 27;62(9):
pubmed: 29941654
J Antimicrob Chemother. 2016 May;71(5):1217-22
pubmed: 26825120
Antimicrob Agents Chemother. 2017 Jan 24;61(2):
pubmed: 27855076
Sci Rep. 2021 Aug 3;11(1):15732
pubmed: 34344951
Front Microbiol. 2019 Jun 20;10:1413
pubmed: 31281303
J Med Microbiol. 2021 Feb;70(2):
pubmed: 33270001
Antimicrob Agents Chemother. 2021 Feb 16;:
pubmed: 33593832
Clin Microbiol Infect. 2014 Sep;20(9):839-53
pubmed: 24813781
J Clin Microbiol. 2015 May;53(5):1731-5
pubmed: 25694522
J Pharm Biomed Anal. 2021 Apr 15;197:113944
pubmed: 33588299
Front Microbiol. 2021 Feb 09;12:641415
pubmed: 33633720
J Clin Microbiol. 2011 Sep;49(9):3222-7
pubmed: 21775535
Antimicrob Agents Chemother. 2017 Apr 24;61(5):
pubmed: 28264839
Clin Microbiol Rev. 2010 Jan;23(1):160-201
pubmed: 20065329
J Med Microbiol. 2014 May;63(Pt 5):772-776
pubmed: 24591705
J Antimicrob Chemother. 2012 Jul;67(7):1597-606
pubmed: 22499996
Clin Microbiol Infect. 2012 May;18(5):432-8
pubmed: 22507110
J Clin Pathol. 1977 Nov;30(11):1030-2
pubmed: 304072
mSphere. 2021 Apr 28;6(2):
pubmed: 33910990
J Antimicrob Chemother. 2015 Nov;70(11):3014-22
pubmed: 26260131
J Biol Chem. 2020 Dec 4;295(49):16604-16613
pubmed: 32963107
Emerg Infect Dis. 2012 Sep;18(9):1503-7
pubmed: 22932472
J Glob Antimicrob Resist. 2022 Jun;29:116-119
pubmed: 35231657
Folia Microbiol (Praha). 2015 Mar;60(2):119-29
pubmed: 25261959
J Clin Microbiol. 2011 Sep;49(9):3321-4
pubmed: 21795515
J Clin Microbiol. 2012 Jul;50(7):2441-3
pubmed: 22553235
Diagn Microbiol Infect Dis. 2018 Feb;90(2):148-150
pubmed: 29150370

Auteurs

Vendula Studentova (V)

Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Alej Svobody 76, 323 00, Pilsen, Czech Republic.
Department of Microbiology, Faculty of Medicine in Pilsen, Charles University, Alej Svobody 80, 323 00, Pilsen, Czech Republic.

Vendula Sudova (V)

Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Alej Svobody 76, 323 00, Pilsen, Czech Republic.
Department of Clinical Biochemistry and Haematology, Faculty of Medicine in Pilsen, Charles University, Alej Svobody 80, 323 00, Pilsen, Czech Republic.

Ibrahim Bitar (I)

Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Alej Svobody 76, 323 00, Pilsen, Czech Republic.
Department of Microbiology, Faculty of Medicine in Pilsen, Charles University, Alej Svobody 80, 323 00, Pilsen, Czech Republic.

Veronika Paskova (V)

Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Alej Svobody 76, 323 00, Pilsen, Czech Republic.
Department of Microbiology, Faculty of Medicine in Pilsen, Charles University, Alej Svobody 80, 323 00, Pilsen, Czech Republic.

Jiri Moravec (J)

Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Alej Svobody 76, 323 00, Pilsen, Czech Republic.

Petr Pompach (P)

Institute of Microbiology of the Czech Academy of Sciences, BIOCEV, Prumyslova 595, 252 50, Vestec, Czech Republic.

Michael Volny (M)

Institute of Microbiology of the Czech Academy of Sciences, BIOCEV, Prumyslova 595, 252 50, Vestec, Czech Republic.

Petr Novak (P)

Institute of Microbiology of the Czech Academy of Sciences, BIOCEV, Prumyslova 595, 252 50, Vestec, Czech Republic.

Jaroslav Hrabak (J)

Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Alej Svobody 76, 323 00, Pilsen, Czech Republic. Jaroslav.Hrabak@lfp.cuni.cz.
Department of Microbiology, Faculty of Medicine in Pilsen, Charles University, Alej Svobody 80, 323 00, Pilsen, Czech Republic. Jaroslav.Hrabak@lfp.cuni.cz.

Articles similaires

Vancomycin-associated DRESS demonstrates delay in AST abnormalities.

Ahmed Hussein, Kateri L Schoettinger, Jourdan Hydol-Smith et al.
1.00
Humans Drug Hypersensitivity Syndrome Vancomycin Female Male
Photosynthesis Ribulose-Bisphosphate Carboxylase Carbon Dioxide Molecular Dynamics Simulation Cyanobacteria
Humans Arthroplasty, Replacement, Elbow Prosthesis-Related Infections Debridement Anti-Bacterial Agents
Vancomycin Polyesters Anti-Bacterial Agents Models, Theoretical Drug Liberation

Classifications MeSH